Clinical trial

EPO906 Therapy in Patients With Advanced Breast Cancer

NCT00035126

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2002-01-01

PhasePHASE2

Study timeline

Study start (actual)2002-01-01Date precision: month

Registry last updated2017-02-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Neoplasmsunresolved

Interventions

epothilone bDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

New BrunswickNew Jersey, United States1 LebanonNew Hampshire, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00035126 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.